RESUMEN
We present a case of retrorectal hamartoma (tailgut cyst). Imaging findings on ultrasound, computed tomography and magnetic resonance imaging, pathologic findings, as well as the diagnostic pitfalls during the patient's management are documented. As it is a rare lesion with a non specific clinical presentation, it is usually misdiagnosed. Our aim is to present image characteristics of these lesions in all modalities and include retrorectal hamartomas in our differential diagnosis in patients with lesions with similar image findings.
Asunto(s)
Hamartoma/diagnóstico , Enfermedades del Recto/diagnóstico , Colectomía , Femenino , Procedimientos Quirúrgicos Ginecológicos , Hamartoma/cirugía , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Exenteración Pélvica/métodos , Enfermedades del Recto/cirugía , Tomografía Computarizada por Rayos X , UltrasonografíaRESUMEN
We report a case of renal arteriovenous malformation treated with superselective endovascular embolization using a light mixture of n-butyl-2-cyanoacrylate and Lipiodol. Diagnostic imaging modalities and treatment methods are discussed. In conclusion, successful superselective embolization should be the standard of care.
Asunto(s)
Malformaciones Arteriovenosas/terapia , Embolización Terapéutica , Enbucrilato/análogos & derivados , Aceite Yodado , Arteria Renal/anomalías , Venas Renales/anomalías , Adulto , Embolización Terapéutica/métodos , Femenino , HumanosRESUMEN
UNLABELLED: The goal of this paper is to present our experience with superior vena cava (SVC) stenting, as first line procedure for immediate relief, in patients with malignancy, and its potential influence in the subsequent radiotherapy (XRT). Over a 1-year period, 18 patients with SVC syndrome due to severe stenosis secondary to mediastinal malignancy were referred for stent insertion. A SVC score was used to measure treatment effectiveness. Stent insertion had been successful in 18/18 patients (technical success 100%). All patients experienced symptomatic relief within few hours of the procedure. There were no major complications. In all patients we were able to start radiotherapy (XRT) the next day, after stenting according to our new institutional protocol. All patients were able to comply with the XRT program, perfectly well. CONCLUSIONS: SVC stenting provides immediate significant relief of the very annoying SVC syndrome symptoms, thus facilitating excellent compliance of all the patients to the subsequently XRT protocols. We strongly recommend SVC stenting as first line procedure, in patients with SVC syndrome due to malignancy prior to radiotherapy.